Without Harvard scientist Kseniia Petrova’s expertise, no one can fully unlock the data’s potential, putting crucial ...

Twelve-year-old Abby Martin is battling leukemia, but has used her treatment as a way to help others in the same fight.

"Mural Oncology’s Phase III ovarian cancer trial failure knocks stock by 57%" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Although the latest launch is likely to be beneficial for GEHC’s top-line growth, the stock declined overall ... times more likely to receive a breast cancer diagnosis. GEHC continued that ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases ...

'Biggest Roadblock': U.S. Envoy Reveals Explosive Truth & Real Reason Behind Delay In Ukraine Truce The ongoing war between Russia and Ukraine has hit a major roadblock, and U.S. special envoy ...

Elevation Oncology (NASDAQ:ELEV) lost ~37% in the premarket on Thursday after the company announced its plans to discontinue R&D work related to its antibody-drug conjugate (ADC) EO-3021 in ...